CHANGES OF SYSTEMIC FIBRINOLYTIC AND HEMOSTATIC PARAMETERS DURING LOCAL FIBRINOLYSIS WITH TISSUE-PLASMINOGEN ACTIVATOR (RT-PA)

被引：0
|
作者：
KLEIN, P
ROTH, FJ
RIEGER, H
POPOVCENIC, S
机构：
[1] UNIV BONN,AGGERTALKLIN ENGELSKIRCHEN,W-5300 BONN,GERMANY
[2] UNIV BONN,INST EXPTL HAMATOL,W-5300 BONN,GERMANY
来源：
VASA-JOURNAL OF VASCULAR DISEASES | 1992年 / 21卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
During the local fibrinolysis with rt-PA (2.5 mg/h) systemic plasminogen and alpha 2-antiplasmin activities slightly decrease, but the fibrinolytic system is compensated during the whole treatment. The d-dimer plasma levels increase dependently on the mass of thrombus. Despite the administration of high doses of heparin during the fibrinolysis thrombin is formed, measured as thrombin-antithrombin III complex (TAT).
引用
收藏
页码：249 / 252
页数：4
相关论文
共 50 条
  • [21] Effect size of treatment with recombinant tissue plasminogen activator (rt-PA) on death and dependency
    Bhogal, SK
    Teasell, RW
    Foley, NC
    Speechley, MR
    STROKE, 2004, 35 (06) : E215 - E215
  • [22] Tissue plasminogen activator for minor strokes: The NINDS rt-PA stroke study experience
    STROKE, 2004, 35 (01) : 241 - 241
  • [23] RECOMBINANT TISSUE-PLASMINOGEN ACTIVATOR (RT-PA) FOR VENOOCCLUSIVE LIVER-DISEASE IN PEDIATRIC AUTOLOGOUS BONE-MARROW TRANSPLANT PATIENTS
    YU, LC
    MALKANI, I
    REGUEIRA, O
    ODE, DL
    WARRIER, RP
    AMERICAN JOURNAL OF HEMATOLOGY, 1994, 46 (03) : 194 - 198
  • [24] PHARMACOKINETICS AND SYSTEMIC FIBRINOGENOLYTIC EFFECTS OF RECOMBINANT HUMAN TISSUE-TYPE PLASMINOGEN-ACTIVATOR (RT-PA) IN HUMANS
    VERSTRAETE, M
    BOUNAMEAUX, H
    DECOCK, F
    VANDEWERF, F
    COLLEN, D
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1985, 235 (02): : 506 - 512
  • [25] RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR (RT-PA) - INTERACTION WITH PLASMA-PROTEINS OF THE COAGULATION AND PLASMINOGEN SYSTEMS
    BELL, WR
    TOPOL, EJ
    DANG, CV
    THROMBOSIS AND HAEMOSTASIS, 1985, 54 (01) : 287 - 287
  • [26] Results of recombinant tissue plasminogen activator (rt-PA) usage in the treatment of cerebral infarction (CI)
    Enina, G.
    Miglane, E.
    Tilgale, B.
    Slosberga, E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 65 - 66
  • [27] Thrombolysis with recombinant tissue plasminogen activator (rt-PA) in ischemic branch retinal vein occlusion
    Wellermann, G
    Hattenbach, LO
    Steinkamp, GWK
    Ohrloff, C
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (04) : S646 - S646
  • [28] Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator (rt-PA) in Acute Lower Limb Ischaemia
    Flis, V.
    Kobilica, N.
    Bergauer, A.
    Mrdza, B.
    Milotic, F.
    Stirn, B.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2011, 39 (03) : 1107 - 1112
  • [29] Hepatic veno-occlussive (VOD) treated with recombinant tissue plasminogen activator (rt-PA).
    Lafuente, A
    Mateos, P
    Rodriguez, M
    Kulkarni, S
    Mehta, J
    Singhal, S
    Saso, R
    Gregory, K
    Dark, G
    Treleaven, J
    Powles, R
    BONE MARROW TRANSPLANTATION, 1998, 21 : S240 - S240
  • [30] Intravitreal recombinant tissue plasminogen activator (rt-PA) in experimental retinal vein occlusion in rabbits
    Nehemy, MB
    Passos, E
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U987 - U987
12345